Furan derivatives as EP4 receptor antagonists

Details for Australian Patent Application No. 2004281225 (hide)

Owner Asterand UK Limited

Inventors Clark, David Edward; Fenton, Garry; Oxford, Alexander William; Stuttle, Keith Alfred James; Hynd, George; Harris, Neil Victor; Davis, Richard Jon; Coleman, Robert Alexander; Clark, Kenneth Lyle; Sutton, Jonathan Mark

Agent Shelston IP

Pub. Number AU-B-2004281225

PCT Pub. Number WO2005/037812

Priority 60/512,200 20.10.03 US; 0324269.0 16.10.03 GB

Filing date 15 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 18 November 2010

International Classifications

C07D 307/68 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/037812 Priority application(s): WO2005/037812

18 November 2010 Application Accepted

  Published as AU-B-2004281225

17 March 2011 Standard Patent Sealed

25 October 2012 Assignment Registered

  Asterand UK Limited The patent has been assigned to Asterand UK Acquisition Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281226-Water-soluble glass composition

2004281220-Novel IgG3 antibodies for stimulating phagocytosis